BetterLife Pharma (BETRF) Receivables - Other (2012 - 2016)

BetterLife Pharma has reported Receivables - Other for 5 years, with the latest figure at $866.0 in Q1 2016.

• On a quarterly basis, Receivables - Other fell 77.63% year-over-year to $866.0 in Q1 2016; TTM through Jan 2016 was $866.0, a 74.76% decrease from a year earlier, with the FY2016 full-year figure at $866.0, down 80.82% from the prior year.
• Receivables - Other was $866.0 for Q1 2016 at BetterLife Pharma, down from $3871.4 in the prior quarter.
• The five-year high for Receivables - Other was $5432.1 in Q4 2014, with the low at -$1989.0 in Q2 2012.
• Average Receivables - Other over 5 years is $1531.3, with a median of $866.0 recorded in 2016.
• The largest YoY upside for Receivables - Other was 41543.03% in 2014 against a maximum downside of 138.32% in 2014.
• Over 5 years, Receivables - Other stood at -$566.0 in 2012, then jumped by 314.46% to $1213.8 in 2013, then soared by 347.52% to $5432.1 in 2014, then dropped by 28.73% to $3871.4 in 2015, then slumped by 77.63% to $866.0 in 2016.
• The last three Receivables - Other figures came in at $866.0 (Q1 2016), $3871.4 (Q1 2015), and $5432.1 (Q4 2014), per Business Quant data.